Document Detail


Risk Stratification and Outcome of Patients with Hypertrophic Cardiomyopathy over 60 Years of Age.
MedLine Citation:
PMID:  23275385     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is prominently associated with risk for sudden death (SD) and disease progression, largely in young patients. Whether patients of more advanced age harbor similar risks is unresolved, often creating clinical dilemmas, particularly in decisions for primary prevention of SD with implantable defibrillators. METHODS AND RESULTS: We studied 428 consecutive HCM patients presenting at ≥ 60 years, followed 5.8 ± 4.8 years; 53% were women. Of 428 patients, 279 (65%) survived to ages 73 ± 7 (range 61-96), most of these (n = 245; 88%) with no/mild symptoms, including 135 with ≥ 1 conventional SD risk factors and 50 (37%) with late gadolinium enhancement. Over follow-up, 149 (35%) died at80 ± 8 years, most from non-HCM related causes (n = 133; 31%), including a substantial proportion from non-cardiac disease (n = 54). Sixteen patients (3.7%) had HCM-related mortality events (0.64%/year), including embolic stroke (n = 6), progressive heart failure or transplant (n = 3), postoperative complications (n = 2), arrhythmic SD events (n = 5; 1.2%; 0.20%/year). All-cause mortality was increased in HCM patients ≥ 60 years compared to an age matched U.S. general population, due predominantly to non-HCM-related diseases (p < 0.001; SMR 1.5). CONCLUSIONS: HCM patients surviving into the seventh decade of life are at low risk for disease-related morbidity/mortality, including SD, even with conventional risk factors. These data do not support aggressive prophylactic defibrillator implantation at advanced ages in HCM. Other cardiac or non-cardiac co-morbidities have greater impact on survival than HCM in older patients.
Authors:
Barry J Maron; Ethan J Rowin; Susan A Casey; Tammy S Haas; Raymond H M Chan; James E Udelson; Ross F Garberich; John R Lesser; Evan Appelbaum; Warren J Manning; Martin S Maron
Related Documents :
24772365 - Long-term mortality analysis in parkinson's disease treated with deep brain stimulation.
15487695 - Minimal intensity diode laser (810 nanometer) photocoagulation (mip) for diffuse diabet...
20643395 - Incidence rates and risk factors for ocular complications and vision loss in hla-b27-as...
15489475 - Management of primary rhegmatogenous retinal detachment with inferior breaks.
10906295 - Iliac occlusions: stenting or crossover grafting? an examination of patency and cost.
24660645 - Low-level laser therapy for management of tmj osteoarthritis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-30
Journal Detail:
Title:  Circulation     Volume:  -     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 Minneapolis Heart Institute Foundation, Minneapolis, MN;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Novel insights into the critical role of bradykinin and the kinin B2 receptor for vascular recruitme...
Next Document:  Thunderstorm asthma: an overview of the evidence base and implications for public health advice.